(0.11%) 5 333.00 points
(0.03%) 40 150 points
(0.17%) 18 667 points
(-0.05%) $80.02
(0.88%) $2.65
(1.10%) $2 444.10
(2.93%) $32.18
(0.29%) $1 093.20
(0.00%) $0.920
(-0.02%) $10.67
(0.07%) $0.788
(-0.25%) $90.75
@ $49.81
Issued: 14 Feb 2024 @ 15:43
Return: -23.79%
Previous signal: Feb 13 - 10:40
Previous signal:
Return: 1.67 %
Live Chart Being Loaded With Signals
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity...
Stats | |
---|---|
Today's Volume | 737 067 |
Average Volume | 569 582 |
Market Cap | 2.31B |
EPS | $0 ( 2024-05-07 ) |
Next earnings date | ( $-2.16 ) 2024-06-18 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -8.20 |
ATR14 | $0.0680 (0.18%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-09 | Shulman Joseph | Sell | 3 984 | Stock Option (right to buy) |
2024-05-09 | Shulman Joseph | Buy | 3 984 | Common Stock |
2024-05-09 | Shulman Joseph | Sell | 3 484 | Common Stock |
2024-05-09 | Shulman Joseph | Sell | 500 | Common Stock |
2024-04-14 | Mazabraud Yann | Sell | 10 375 | Common Stock |
INSIDER POWER |
---|
40.82 |
Last 100 transactions |
Buy: 1 136 201 | Sell: 472 596 |
Volume Correlation
Rhythm Pharmaceuticals Correlation
10 Most Positive Correlations | |
---|---|
NERV | 0.815 |
10 Most Negative Correlations | |
---|---|
EXC | -0.823 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Rhythm Pharmaceuticals Correlation - Currency/Commodity
Rhythm Pharmaceuticals Financials
Annual | 2023 |
Revenue: | $77.43M |
Gross Profit: | $68.13M (87.99 %) |
EPS: | $-3.20 |
FY | 2023 |
Revenue: | $77.43M |
Gross Profit: | $68.13M (87.99 %) |
EPS: | $-3.20 |
FY | 2022 |
Revenue: | $23.64M |
Gross Profit: | $21.51M (90.98 %) |
EPS: | $-3.51 |
FY | 2021 |
Revenue: | $3.15M |
Gross Profit: | $2.56M (81.01 %) |
EPS: | $-1.400 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is also developing setmelanotide, which is in Phase II clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, Smith-Magenis syndrome obesity, POMC epigenetic disorders, and other MC4R disorders. Rhythm Pharmaceuticals, Inc. has a collaborative research agreement with the Clinical Registry Investigating Bardet-Biedl Syndrome. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. Rhythm Pharmaceuticals, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators